Grayzel David S.

Director at JBIO; Director at Surface Oncology, Inc.

Sold, on record
$31.1M
Dollars the filings state
Form 4 sales
2
Latest Apr 9, 2024
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale Surface Oncology, Inc.Unusual
    Dec 17, 2020 2020

    Sold 1.7M shares at $18.10 ($30.8M)

    Grayzel David S., Director

    Sold 36.6% of holdings ($84.1M position)2.9M shares leftFirst sale on recordFiling

  2. 2 Form 4 sale JBIOUnusual
    Apr 9, 2024 +1209 days

    Sold 11,882 shares at $28.15 ($334k)

    Grayzel David S., Director

    No 10b5-1 planSold 45% of holdings ($743k position)14,502 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by Grayzel David S.
Source
Apr 9, 2024Apr 11, 2024JBIODirectorForm 4 sale11,882$334k45.0%UnusualSEC
Dec 17, 2020Dec 21, 2020Surface Oncology, Inc.DirectorForm 4 sale1.7M$30.8M36.6%UnusualSEC